Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat
- 31 March 1990
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 100 (4) , 464-469
- https://doi.org/10.1007/bf02243997
Abstract
Behavioral effects of nicotine and cytisine, and the cholinesterase inhibitors physostigmine and 9-amino-1,2,3,4-tetrahydroacridine (THA), administered intrathecally (IT) at the lumbar level in the rat have been evaluated. Antinociceptive dose relationships were established using the tail immersion test. Total activity, locomotion and rearing were also measured in computerized test boxes. The nicotinic receptor antagonist, mecamylamine, and the muscarinic receptor antagonist, atropine, were used to study the selectivity of the effects. Physostigmine and THA significantly decreased total activity, locomotion and rearing as compared to control animals. The motor effects of physostigmine were completely antagonized by atropine whereas those of THA were antagonized only partly. Mecamylamine had no antagonistic effect. Nicotine did not affect any activity parameter. Cytisin reduced total activity and locomotion 1–6 min after dose. IT physostigmine, 15 µg, increased tail immersion latency for 30 min. No significant increase in response latency in this test was observed after the IT administration of nicotine or THA, whereas cytisine elicited a small increase. The IT administration of THA, nicotine and cytisine was also associated with gnawing, vocalization and hyperactivity and in the case of THA, diarrhoea. These effects were blocked by mecamylamine. Physostigmine antinociception as well as the behavioral effects including total activity, locomotion and rearing caused by physostigmine and by THA are most probably due to an action on spinal muscarinic receptors. Nicotinic receptors do not seem to be involved in spinal antinociception. Some aversive behavioral effects caused by the IT administration of nicotinic receptor agonists could, however, be attenuated by the spinal administration of the antagonist mecamylamine, which may indicate the involvement of nicotinic receptors in afferent sensory transmission.Keywords
This publication has 27 references indexed in Scilit:
- Characterization of the Antinociception Induced by Intrathecally Administered CarbacholBasic & Clinical Pharmacology & Toxicology, 1989
- Interactions between noradrenergic and cholinergic mechanisms involved in spinal nociceptive processingActa Anaesthesiologica Scandinavica, 1989
- Substance P, nicotinic acetylcholine receptors and antinociception in the ratNeuropharmacology, 1987
- Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- The spinal cord as a major site for the antinociceptive action of nicotine in the ratNeuropharmacology, 1986
- A double‐blind trial of the analgesic properties of physostigmine in postoperative patientsActa Anaesthesiologica Scandinavica, 1986
- Effects of spinal cord lesions and rhizotomies on cholinergic and opiate receptor binding sites in rat spinal cordActa Physiologica Scandinavica, 1986
- Comparative Analysis of Nicotine-Like Receptor-Ligand Interactions in Rodent Brain HomogenateJournal of Neurochemistry, 1985
- Interaction between nicotine and endogenous opioid mechanisms in the unanesthetized dogPharmacology Biochemistry and Behavior, 1982
- A cholinergic mechanism in the spinal cord of catsNeuropharmacology, 1974